Myopia Control For Everyone - Be Seen™

Save 25% on your 1st order
Contact Us

Myopia Control For Everyone

Nerdy Frames
Nerdy Frames Nov 06, 2024

MYOPIA CONTROL IS IMPORTANT

Written November 2024: Myopia has reached epidemic proportions. Once seen as an eye condition mainly experienced by children, it now affects approximately 25 percent of a quarter of young adults. There are Myopia control options currently available to help solve this issue. A 2022 report in “Front Public Health, Prevalence and Risk Factors of Myopia in Young Adults: Review of Findings From the Raine Study” (ncbi.nlm.nih.gov/pmc/articles/PMC9092372) found that by age 28, myopia prevalence had increased to more than 33 percent. As people lead a more digital lifestyle and perform more near tasks, this number is expected to continue to increase globally. A study in “Ophthalmology, Global Prevalence of Myopia and High Myopia and Temporal Trends” from 2000 through 2050 (pubmed.ncbi.nlm.nih.gov/26875007), reports that nearly 50 percent of the world population will have myopia by 2050, of which 938 million people will have high myopia.

POTENTIAL EYE ISSUES

Without adequate treatment, myopia can lead to a host of other serious vision problems, including myopic macular degeneration (MMD), glaucoma, cataracts and retinal detachment. Treatment options vary from country to country, with both spectacle lenses and contact lenses available in many parts of the world.

CURRENT LENS SOLUTIONS

In the United States, the Food and Drug Administration (FDA) has approved myopia control contact lenses such as CooperVision’s MiSight and Johnson & Johnson Vision’s Acuvue Abiliti. Yet the agency has yet to approve any myopia control spectacle lenses.

(The FDA has granted Essilor’s Stellest spectacle lenses the Breakthrough Device designation. The FDA’s Breakthrough Devices Program is intended to provide patients and health care professionals with timely access to medical devices that offer more effective treatment or diagnosis of life-threatening or irreversibly debilitating diseases or conditions by speeding up their development, assessment and review.)

Our friends in Canada currently have technology such as Hoya MiYOSMART, SightGlass, Zeiss MyoCare and Essilor Stellest at their disposal. Out of the above mentioned, SightGlass is the only lens studied on 6-year-olds, where excellent results have emerged from their clinical studies.

NERDY FRAMES ACTION: MYOPIA CONTROL LOBBYING

Nerdy Frames is championing the use of these spectacle lens technology here in the United States. We are currently lobbying in New York and Ohio, where our share headquarters reside. We believe that this technology will help prevent further eye conditions not only for children but also adults. Additionally, offering these lenses to our overall lens solutions options would be beneficial to our client base.

How can we help you?

 

The Company

 

Resources

 

Vision Insurance Information

How Insurance Reimbursement Works

Unfortunately, we don't have any direct partnerships with vision insurance providers, but we can assist you in getting a reimbursement for your purchase after you have paid in full at the time of purchase. In order to be reimbursed, you will first need to fill out a form from your insurance provider. After you fill out their reimbursement form, you will need to provide an itemized receipt, which we can provide you with once you have completed your purchase. We've provided some links below of popular vision insurance providers to help you get started.

Please contact your vision insurance for more information on how to file for a reimbursement.

If you have any question or you need an itemized receipt, please email us at info@nerdyframes.com

VSP Claim Form EyeMed Claim Form Davis Vision Claim Form

FSA & HSA Payments

We accept both FSA and HSA payments, as long as they are in the form of a credit or debit card. After you have had completed a purchase with your FSA/HSA, you can then file for a reimbursement with your vision insurance provider.